MX2023007818A - Analisis del factor de transcripcion circulante. - Google Patents
Analisis del factor de transcripcion circulante.Info
- Publication number
- MX2023007818A MX2023007818A MX2023007818A MX2023007818A MX2023007818A MX 2023007818 A MX2023007818 A MX 2023007818A MX 2023007818 A MX2023007818 A MX 2023007818A MX 2023007818 A MX2023007818 A MX 2023007818A MX 2023007818 A MX2023007818 A MX 2023007818A
- Authority
- MX
- Mexico
- Prior art keywords
- transcription factor
- circulating
- factor analysis
- subject
- methods
- Prior art date
Links
- 108091023040 Transcription factor Proteins 0.000 title abstract 2
- 102000040945 Transcription factor Human genes 0.000 title abstract 2
- 238000000556 factor analysis Methods 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 210000001124 body fluid Anatomy 0.000 abstract 2
- 239000010839 body fluid Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108010077544 Chromatin Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108010047956 Nucleosomes Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000003483 chromatin Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 210000001623 nucleosome Anatomy 0.000 abstract 1
- 238000012163 sequencing technique Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2545/00—Reactions characterised by their quantitative nature
- C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
- C12Q2545/114—Reactions characterised by their quantitative nature the purpose being quantitative analysis involving a quantitation step
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/131—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063131722P | 2020-12-29 | 2020-12-29 | |
| PCT/EP2021/087813 WO2022144407A1 (en) | 2020-12-29 | 2021-12-29 | Circulating transcription factor analysis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023007818A true MX2023007818A (es) | 2023-09-05 |
Family
ID=79927307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023007818A MX2023007818A (es) | 2020-12-29 | 2021-12-29 | Analisis del factor de transcripcion circulante. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240318226A1 (enExample) |
| EP (1) | EP4271833A1 (enExample) |
| JP (1) | JP2024501063A (enExample) |
| KR (1) | KR20230132485A (enExample) |
| CN (1) | CN116917496A (enExample) |
| AU (1) | AU2021414296A1 (enExample) |
| CA (1) | CA3206465A1 (enExample) |
| IL (1) | IL303977A (enExample) |
| MX (1) | MX2023007818A (enExample) |
| TW (1) | TW202242130A (enExample) |
| WO (1) | WO2022144407A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115851951A (zh) * | 2022-12-12 | 2023-03-28 | 广州优泽生物技术有限公司 | 含多组学标志物组合物的早期肝癌检测模型构建及试剂盒 |
| US20260028678A1 (en) * | 2022-12-19 | 2026-01-29 | Belgian Volition Srl | Assessment of biological samples for nucleic acid analysis |
| GB202303562D0 (en) * | 2023-03-10 | 2023-04-26 | Belgian Volition Sprl | Sample collection for liquid biopsy |
| TW202530419A (zh) | 2023-10-04 | 2025-08-01 | 比利時商比利時意志有限公司 | Pcr方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6803195B1 (en) * | 1999-07-02 | 2004-10-12 | Ramot At Tel-Aviv University Ltd. | Facile detection of cancer and cancer risk based on level of coordination between alleles |
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115098D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| JP6263474B2 (ja) | 2011-12-07 | 2018-01-17 | シンガポール ボリション ピーティーイー リミテッド | ヌクレオソームアダクト検出法 |
| CN107002122B (zh) * | 2014-07-25 | 2023-09-19 | 华盛顿大学 | 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法 |
| US10453556B2 (en) | 2015-07-23 | 2019-10-22 | The Chinese University Of Hong Kong | Analysis of fragmentation patterns of cell-free DNA |
| ES2779798T3 (es) * | 2015-08-12 | 2020-08-19 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Métodos para estudiar ácidos nucleicos |
| WO2017034970A1 (en) * | 2015-08-21 | 2017-03-02 | The General Hospital Corporation | Combinatorial single molecule analysis of chromatin |
| GB201604806D0 (en) * | 2016-03-22 | 2016-05-04 | Singapore Volition Pte Ltd | Method of identifying a cancer of unknown origin |
| CN112119166B (zh) * | 2018-03-13 | 2025-08-22 | 耶路撒冷希伯来大学伊萨姆研发有限公司 | 无细胞dna染色质免疫沉淀的诊断应用 |
| WO2020206143A1 (en) * | 2019-04-05 | 2020-10-08 | Claret Bioscience, Llc | Methods and compositions for analyzing nucleic acid |
| TW202242145A (zh) * | 2020-12-29 | 2022-11-01 | 比利時商比利時意志有限公司 | 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析 |
-
2021
- 2021-12-28 TW TW110149064A patent/TW202242130A/zh unknown
- 2021-12-29 EP EP21847723.0A patent/EP4271833A1/en active Pending
- 2021-12-29 MX MX2023007818A patent/MX2023007818A/es unknown
- 2021-12-29 AU AU2021414296A patent/AU2021414296A1/en active Pending
- 2021-12-29 WO PCT/EP2021/087813 patent/WO2022144407A1/en not_active Ceased
- 2021-12-29 IL IL303977A patent/IL303977A/en unknown
- 2021-12-29 CA CA3206465A patent/CA3206465A1/en active Pending
- 2021-12-29 CN CN202180094755.0A patent/CN116917496A/zh active Pending
- 2021-12-29 US US18/260,018 patent/US20240318226A1/en active Pending
- 2021-12-29 JP JP2023539832A patent/JP2024501063A/ja active Pending
- 2021-12-29 KR KR1020237025577A patent/KR20230132485A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022144407A1 (en) | 2022-07-07 |
| TW202242130A (zh) | 2022-11-01 |
| IL303977A (en) | 2023-08-01 |
| JP2024501063A (ja) | 2024-01-10 |
| CN116917496A (zh) | 2023-10-20 |
| CA3206465A1 (en) | 2022-07-07 |
| EP4271833A1 (en) | 2023-11-08 |
| KR20230132485A (ko) | 2023-09-15 |
| US20240318226A1 (en) | 2024-09-26 |
| AU2021414296A1 (en) | 2023-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122871T1 (el) | Μεθοδος ποσοτικου προσδιορισμου για την εκφραση της pd-l1 | |
| MY209429A (en) | Use of cas protein, method for detecting target nucleic acid molecule, and kit | |
| BR112016027848A2 (pt) | Método para avaliação de número de cópias de uma sequência de interesse, meio legível por máquina não transitória, e, sistema para avaliação de número de cópias de uma sequência de interesse | |
| HK1256412A1 (zh) | 基於变体的疾病诊断和追踪 | |
| BR112018007040A2 (pt) | método e aparelho para detectar e classificar a atividade convulsiva | |
| EP4282405A3 (en) | Detection of cancer biomarkers using nanoparticles | |
| SG10201903822XA (en) | Method for the enrichment of circulating tumor dna | |
| BR112017012222A2 (pt) | métodos para derivar um biomarcador de assinatura gênica e para tratar um paciente que tem um tumor, método e sistema para testar uma amostra de tumor removida de um paciente, e, kit. | |
| EP3239305A3 (en) | Use of microvesicles in diagnosis and prognosis of medical diseases and conditions | |
| WO2010136163A8 (en) | Secernin-1 as a marker for cancer | |
| EP3654036A3 (en) | Stomach cancer biomarker and detection method | |
| WO2016127077A3 (en) | Systems and methods for detection and analysis of biological species | |
| EP4276190A3 (en) | Methods for the diagnosis of bacterial vaginosis | |
| WO2010084327A3 (en) | Methods | |
| WO2016205828A3 (en) | Role of citrullination in diagnosing diseases | |
| WO2016034715A3 (fr) | Methode de prediction de l'evolution clinique du cancer colorectal | |
| ZA202207531B (en) | Methods of diagnosing and treating cervical cancer | |
| WO2010000467A8 (en) | Asc as a marker for lung cancer | |
| MX2016014779A (es) | Prueba de diagnostico y tratamiento/prevencion de la enfermedad de alzheimer. | |
| KR102302234B9 (ko) | 검출정보별 판별 분석을 실시하여 개인을 식별하는 장치 및 방법 | |
| MX2022016097A (es) | Procedimientos para detectar y predecir neoplasia epitelial cervical de grado 3 (cin3) y/o cáncer. | |
| DE60202081D1 (de) | Verfahren zur verbesserten Diagnose von Dysplasien | |
| AU2003302440A8 (en) | Nucleic acid probes and method for detecting a target nucleic acid sequence comprise two or more cis- located nucleic acid regions | |
| WO2022046653A3 (en) | Diagnostic and therapeutic for the identification and treatment of sars-cov-2 | |
| MY187887A (en) | Strongyloides stercoralis protein and/or corresponding dna and rna sequences for application in diagnosis |